Cargando…

Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)

Intraoperative radiotherapy (IORT) is a precise, single high-dose irradiation directly targeting the tumor bed during surgery. In comparison with traditional external beam RT, it minimizes damage to other normal tissues, ensures an adequate dose to the tumor bed and results in improved cosmetic outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Hou, Xiaochen, Kong, Shujia, Zha, Zhuocen, Huang, Mingqing, Li, Chenxi, Li, Na, Ge, Fei, Chen, Wenlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636769/
https://www.ncbi.nlm.nih.gov/pubmed/37888611
http://dx.doi.org/10.3892/mmr.2023.13118
_version_ 1785133266604392448
author Yang, Yang
Hou, Xiaochen
Kong, Shujia
Zha, Zhuocen
Huang, Mingqing
Li, Chenxi
Li, Na
Ge, Fei
Chen, Wenlin
author_facet Yang, Yang
Hou, Xiaochen
Kong, Shujia
Zha, Zhuocen
Huang, Mingqing
Li, Chenxi
Li, Na
Ge, Fei
Chen, Wenlin
author_sort Yang, Yang
collection PubMed
description Intraoperative radiotherapy (IORT) is a precise, single high-dose irradiation directly targeting the tumor bed during surgery. In comparison with traditional external beam RT, it minimizes damage to other normal tissues, ensures an adequate dose to the tumor bed and results in improved cosmetic outcomes and quality of life. Furthermore, IORT offers a shorter treatment duration, lower economic costs and therapeutic efficacy comparable with traditional RT. However, its relatively higher local recurrence rate limits its further clinical applications. Identifying effective radiosensitizing drugs and rational RT protocols will improve its advantages. Furthermore, IORT may not only damage DNA to directly kill breast tumor cells but also alter the tumor microenvironment (TME) to exert a sustained antitumor effect. Specific doses of IORT may exert anti-angiogenic effects, and consequently antitumor effects, by impacting post-radiation peripheral blood levels of vascular endothelial growth factor and delta-like 4. IORT may also modify the postoperative wound fluid composition to continuously inhibit tumor growth, e.g. by reducing components such as microRNA (miR)-21, miR-221, miR-115, oncostatin M, TNF-β, IL-6 and IL-8, and by elevating levels of components such as miR-223, to inhibit the ability of postoperative wound fluid to induce proliferation, invasion and migration of residual cancer cells. IORT can also modify cancer cell glucose metabolism to inhibit the proliferation of residual tumor cells. In addition, IORT can induce a bystander effect, eliminating the postoperative wound fluid-induced epithelial-mesenchymal transition and tumor stem cell phenotype. Insights gained at the molecular level may provide new directions for identifying novel therapeutic targets and approaches. A more comprehensive understanding of the effects of IORT on the breast cancer (BC) TME may further its clinical application. Hence, the present article reviews the primary effects of IORT on BC and its impact on the TME, aiming to offer fresh research perspectives for relevant professionals.
format Online
Article
Text
id pubmed-10636769
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-106367692023-11-11 Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review) Yang, Yang Hou, Xiaochen Kong, Shujia Zha, Zhuocen Huang, Mingqing Li, Chenxi Li, Na Ge, Fei Chen, Wenlin Mol Med Rep Review Intraoperative radiotherapy (IORT) is a precise, single high-dose irradiation directly targeting the tumor bed during surgery. In comparison with traditional external beam RT, it minimizes damage to other normal tissues, ensures an adequate dose to the tumor bed and results in improved cosmetic outcomes and quality of life. Furthermore, IORT offers a shorter treatment duration, lower economic costs and therapeutic efficacy comparable with traditional RT. However, its relatively higher local recurrence rate limits its further clinical applications. Identifying effective radiosensitizing drugs and rational RT protocols will improve its advantages. Furthermore, IORT may not only damage DNA to directly kill breast tumor cells but also alter the tumor microenvironment (TME) to exert a sustained antitumor effect. Specific doses of IORT may exert anti-angiogenic effects, and consequently antitumor effects, by impacting post-radiation peripheral blood levels of vascular endothelial growth factor and delta-like 4. IORT may also modify the postoperative wound fluid composition to continuously inhibit tumor growth, e.g. by reducing components such as microRNA (miR)-21, miR-221, miR-115, oncostatin M, TNF-β, IL-6 and IL-8, and by elevating levels of components such as miR-223, to inhibit the ability of postoperative wound fluid to induce proliferation, invasion and migration of residual cancer cells. IORT can also modify cancer cell glucose metabolism to inhibit the proliferation of residual tumor cells. In addition, IORT can induce a bystander effect, eliminating the postoperative wound fluid-induced epithelial-mesenchymal transition and tumor stem cell phenotype. Insights gained at the molecular level may provide new directions for identifying novel therapeutic targets and approaches. A more comprehensive understanding of the effects of IORT on the breast cancer (BC) TME may further its clinical application. Hence, the present article reviews the primary effects of IORT on BC and its impact on the TME, aiming to offer fresh research perspectives for relevant professionals. D.A. Spandidos 2023-10-25 /pmc/articles/PMC10636769/ /pubmed/37888611 http://dx.doi.org/10.3892/mmr.2023.13118 Text en Copyright: © Yang et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Yang, Yang
Hou, Xiaochen
Kong, Shujia
Zha, Zhuocen
Huang, Mingqing
Li, Chenxi
Li, Na
Ge, Fei
Chen, Wenlin
Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title_full Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title_fullStr Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title_full_unstemmed Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title_short Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review)
title_sort intraoperative radiotherapy in breast cancer: alterations to the tumor microenvironment and subsequent biological outcomes (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636769/
https://www.ncbi.nlm.nih.gov/pubmed/37888611
http://dx.doi.org/10.3892/mmr.2023.13118
work_keys_str_mv AT yangyang intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT houxiaochen intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT kongshujia intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT zhazhuocen intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT huangmingqing intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT lichenxi intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT lina intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT gefei intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview
AT chenwenlin intraoperativeradiotherapyinbreastcanceralterationstothetumormicroenvironmentandsubsequentbiologicaloutcomesreview